Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-045205
Filing Date
2006-03-06
Accepted
2006-03-03 17:35:37
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1242204
2 GLOBAL NOTE dex48.htm EX-4.8 48137
3 SEVERANCE AGREEMENT dex1020.htm EX-10.20 16727
4 TERMINATION AGREEMENT dex1027.htm EX-10.27 12505
5 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12.htm EX-12 29820
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 3127
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6217
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6584
9 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4291
  Complete submission text file 0001193125-06-045205.txt   1371274
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 06665229
SIC: 2836 Biological Products, (No Diagnostic Substances)